CD22 and Siglec-G in B cell function and tolerance

Trends in Immunology

Volumn 33, Issue 8, 2012, Pages 413-420

  Poe, Jonathan C ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B cells; CD22; Siglec G; TI 2 Ag

Indexed keywords

ANTIGEN; AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD22 ANTIGEN; CD24 ANTIGEN; CD40 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; SIGLEC 1; SIGLEC 2; SIGLEC 3; SIGLEC G; T CELL INDEPENDENT TYPE 2 ANTIGEN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; GENE EXPRESSION REGULATION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD22; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; LECTINS; RECEPTORS, ANTIGEN, B-CELL;

EID: 84864144129     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.04.010     Document Type: Review

References (76)

1. Goodnow C.C., et al. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 1989, 342:385-391.
2. Klinman N.R. The " clonal selection hypothesis" and current concepts of B cell tolerance. Immunity 1996, 5:189-195.
3. Merrell K.T., et al. Identification of anergic B cells within a wild-type repertoire. Immunity 2006, 25:953-962.
4. Gauld S.B., et al. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat. Immunol. 2005, 6:1160-1167.
5. Goodnow C.C., et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676-682.
6. O'Neill S.K., et al. Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6262-6267.
7. Smith S.H., et al. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int. Immunol. 2010, 22:681-691.
8. Stadanlick J.E., Cancro M.P. BAFF and the plasticity of peripheral B cell tolerance. Curr. Opin. Immunol. 2008, 20:158-161.
9. Poe J.C., et al. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat. Immunol. 2004, 5:1078-1087.
10. Poe J.C., et al. Severely-impaired B lymphocyte proliferation, survival and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J. Immunol. 2004, 172:2100-2110.
11. Poe J.C., et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE 2011, 6:e22464.
12. DiLillo D.J., et al. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N. Y. Acad. Sci. 2010, 1183:38-57.
13. Dintzis R.Z., et al. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. J. Immunol. 1989, 143:1239-1244.
14. Mond J.J., et al. T cell-independent antigens type 2. Annu. Rev. Immunol. 1995, 13:655-692.
15. Perlmutter R.M., et al. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 1978, 121:566-572.
16. Haas K.M., et al. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 2002, 17:713-723.
17. Haas K.M., et al. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005, 23:7-18.
18. Martin F., et al. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
19. Fagarasan S., Honjo T. T-Independent immune response: new aspects of B cell biology. Science 2000, 290:89-92.
20. Martin F., Kearney J.F. Marginal-zone B cells. Nat. Rev. Immunol. 2002, 2:323-335.
21. Maseda D., et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 2012, 188:1036-1048.
22. Yanaba K., et al. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 2009, 182:7459-7472.
23. Crocker P.R., et al. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 2007, 7:255-266.
24. Tedder T.F., et al. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu. Rev. Immunol. 1997, 15:481-504.
25. Hoffmann A., et al. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat. Immunol. 2007, 8:695-704.
26. Jellusova J., et al. Siglec-G regulates B1 cell survival and selection. J. Immunol. 2010, 185:3277-3284.
27. Nitschke L. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol. Rev. 2009, 230:128-143.
28. Duong B.H., et al. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J. Exp. Med. 2009, 207:173-187.
29. Doody G.M., et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995, 269:242-244.
30. Poe J.C., et al. CD22 forms a quaternary complex with SHIP, Grb2 and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J. Biol. Chem. 2000, 275:17420-17427.
31. Engel P., et al. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils and monocytes. J. Immunol. 1993, 150:4719-4732.
32. Engel P., et al. Identification of the ligand binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J. Exp. Med. 1995, 181:1581-1586.
33. Stamenkovic I., Seed B. The B cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 1990, 344:74-77.
34. Kelm S., et al. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 1994, 4:965-972.
35. Powell L.D., et al. Natural ligands of the B cell adhesion molecule CD22β carry N-linked oligosaccharides with α-2,6-linked sialic acids that are required for recognition. J. Biol. Chem. 1993, 268:7019-7027.
36. Powell L.D., Varki A. The oligosaccharide binding specificities of CD22-β, a sialic acid-specific lectin of B-cells. J. Biol. Chem. 1994, 269:10628-10636.
37. Munro S., et al. B lymphocyte surface antigen CD75 is not α-2,6-sialyltransferase but is a carbohydrate antigen modified by the enzyme. Cell 1992, 68:1003-1004.
38. Hanasaki K., et al. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22: selective recognition of immunoglobulin M and haptoglobin. J. Biol. Chem. 1995, 270:7543-7550.
39. Stamenkovic I., et al. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2,6 sialyltransferase, CD75, on B cells. Cell 1991, 66:1133-1144.
40. Pflugh D.L., et al. Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes. J. Immunol. 2002, 169:5130-5136.
41. Leprince C., et al. CD22 associates with the human surface IgM-B cell antigen receptor complex. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:3236-3240.
42. Han S., et al. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat. Chem. Biol. 2005, 1:93-97.
43. Pezzutto A., et al. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp130/140. J. Immunol. 1987, 138:98-103.
44. Tooze R.M., et al. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 1997, 7:59-67.
45. Nitschke L., et al. CD22 is a negative regulator of B-cell receptor signaling. Curr. Biol. 1997, 7:133-143.
46. O'Keefe T.L., et al. Hyperresponsive B cells in CD22-deficient mice. Science 1996, 274:798-801.
47. Otipoby K.L., et al. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996, 384:634-637.
48. Sato S., et al. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 1996, 5:551-562.
49. Sato S., et al. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13158-13162.
50. Fujimoto M., et al. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 1999, 11:191-200.
51. Jin L., et al. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J. Exp. Med. 2002, 195:1199-1205.
52. Kelm S., et al. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med. 2002, 195:1207-1213.
53. Razi N., Varki A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:7469-7474.
54. Collins B.E., et al. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6104-6109.
55. van der Merwe P.A., et al. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J. Biol. Chem. 1996, 271:9273-9280.
56. Lanoue A., et al. Interaction of CD22 with a2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity?. Eur. J. Immunol. 2002, 32:348-355.
57. Law C.-L., et al. Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles. J. Immunol. 1993, 151:175-187.
58. a lupus-prone mice. J. Immunol. 2000, 165:2987-2996.
59. Lajaunias F., et al. Polymorphisms in the Cd22 gene of inbred mouse strains. Immunogenetics 1999, 49:991-995.
60. O'Keefe T.L., et al. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 1999, 189:1307-1313.
61. Schultz L.D., et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993, 73:1445-1454.
62. Kozlowski M., et al. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 1993, 178:2157-2163.
63. Cyster J.G., Goodnow C.C. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995, 2:13-24.
64. Sato S., et al. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 1996, 157:4371-4378.
65. Asano N., et al. B lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am. J. Pathol. 2004, 165:641-650.
66. Whitney G., et al. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur. J. Biochem. 2001, 268:6083-6096.
67. Berland R., Wortis H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 2002, 20:253-300.
68. Jellusova J., et al. CD22 × Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J. Immunol. 2010, 184:3618-3627.
69. Chen G.Y., et al. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 2009, 323:1722-1725.
70. Carlin A.F., et al. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 2009, 113:3333-3336.
71. Haas K.M., et al. CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo. J. Immunol. 2006, 177:3063-3073.
72. O'Reilly M.K., et al. CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells. J. Immunol. 2011, 186:1554-1563.
73. Poe J.C., et al. CD19, CD21 and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 2001, 20:739-762.
74. Seite J.F., et al. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood 2010, 116:1698-1704.
75. Adachi T., et al. CD22 serves as a receptor for soluble IgM. Eur. J. Immunol. 2012, 42:241-247.
76. Samardzic T., et al. Reduction of marginal zone B cells in CD22-deficient mice. Eur. J. Immunol. 2002, 32:561-567.